From Inflammation to Resolution: Therapeutic Insights into Chronic Disease Management

Abstract

Inflammation is a fundamental biological process implicated in various physiological and neurological disorders, including cardiovascular diseases, cancer, diabetes, and neurodegenerative conditions. Chronic inflammation is linked to significant health challenges and mortality worldwide, emphasizing the importance of understanding its mechanisms and resolution. This review elucidates inflammatory processes as essential components of the immune response, highlighting pharmacological interventions for promoting timely inflammation resolution. We explore the dual phases of inflammation—acute and chronic—detailing the complex cellular interactions and signaling pathways that govern the inflammatory response to pathogens and tissue injury. In particular, we emphasize specialized pro-resolving mediators (SPMs), such as lipoxins and resolvins, which play crucial roles in transitioning inflammation from a detrimental to a healing state. Additionally, we discuss innovative therapeutic approaches, including tissue engineering, cellular therapies, and the utilization of SPMs, aimed at enhancing inflammation resolution. The roles of gaseous mediators and peptide/protein mediators in modulating inflammation are also examined. Through this comprehensive analysis, we advocate for the development of pro-resolving treatments to improve outcomes for patients with chronic inflammatory disorders. By understanding the intricate dynamics of inflammation and its resolution, new avenues for targeted therapy emerge, offering promise for mitigating the impacts of chronic inflammatory diseases and enhancing patient quality of life.